Twist Bioscience (TWST) Total Liabilities (2017 - 2026)

Twist Bioscience (TWST) has 10 years of Total Liabilities data on file, last reported at $221.1 million in Q1 2026.

• Total Liabilities for Q1 2026 came in at $221.1 million, up 42.19% year-over-year; the trailing twelve-month figure through Mar 2026 was $221.1 million (up 42.19% YoY), and the FY2025 annual result was $168.9 million, up 19.25% from the prior year.
• Total Liabilities advanced to $221.1 million in Q1 2026 per TWST's latest filing, from $182.0 million in the prior quarter.
• Over five years, Total Liabilities peaked at $221.1 million in Q1 2026 and troughed at $141.6 million in Q3 2024.
• A 5-year average of $160.5 million and a median of $155.5 million in 2025 frame the typical range for Total Liabilities.
• The sharpest annual moves came in 2022 and 2023: Total Liabilities surged 2627.42% in 2022, then fell 12.75% in 2023.
• A 5-year view of Total Liabilities shows it stood at $163.6 million in 2022, then slipped by 12.75% to $142.8 million in 2023, then grew by 6.91% to $152.6 million in 2024, then advanced by 19.23% to $182.0 million in 2025, then climbed by 21.5% to $221.1 million in 2026.
• Business Quant data shows TWST's Total Liabilities at $221.1 million in Q1 2026, $182.0 million in Q4 2025, and $168.9 million in Q3 2025.